Date Filed | Type | Description |
01/04/2022 |
SC 13G
| Domain Partners VIII, L.P. reports a 8.6% stake in SERA PROGNOSTICS, INC. |
01/21/2021 |
SC 13G/A
| Domain Partners VIII, L.P. reports a 0.9% stake in aTyr Pharma, Inc. |
01/20/2021 |
SC 13G/A
| Domain Partners VIII, L.P. reports a 2.5% stake in Syndax Pharmaceuticals, Inc. |
01/20/2021 |
SC 13G/A
| Domain Partners VIII, L.P. reports a 2.9% stake in Milestone Pharmaceuticals Inc. |
01/20/2021 |
SC 13G/A
| Domain Partners VIII, L.P. reports a 0% stake in Bionano Genomics, Inc. |
01/10/2020 |
SC 13G/A
| Domain Partners VIII, L.P. has filed a Schedule 13D for Veracyte, Inc. |
01/09/2020 |
SC 13G
| Domain Partners VIII, L.P. reports a 7.6% stake in Milestone Pharmaceuticals Inc. |
05/13/2019 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on Alliqua BioMedical, Inc. |
05/13/2019 |
SC 13D
| Domain Partners VIII, L.P. reports a 52.3% stake in Adynxx, Inc. |
01/11/2019 |
SC 13G
| Domain Partners VIII, L.P. reports a 9.5% stake in Bionano Genomics, Inc. |
01/11/2019 |
SC 13G/A
| Domain Partners VIII, L.P. reports a 5.6% stake in Veracyte, Inc. |
11/05/2018 |
SC 13D/A
| Domain Partners VIII, L.P. reports a 4.7% stake in Dicerna Pharmaceuticals, Inc. |
08/27/2018 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on BioNano Genomics, Inc
Txns:
| Converted 591,184 shares
@ $0 Converted 337,694 shares
@ $4.59, valued at
$1.6M
Bought 15,000 shares
@ $6.125, valued at
$91.9k
Converted 6,810,098 preferred shares
@ $0 Converted 2,986,762 preferred shares
@ $0 Converted 5,426,808 preferred shares
@ $0 Converted 6,396,105 preferred shares
@ $0 Converted 3,682,919 preferred shares
@ $0 Converted convertible notes
@ $0 Bought 15,000 options to buy
@ $6.125, valued at
$91.9k
|
|
08/21/2018 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on BioNano Genomics, Inc |
01/08/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
12/20/2017 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc
Txns:
| Converted 1,678,432 shares
@ $3.19, valued at
$5.4M
Granted 37,890 shares
@ $0 Converted 49,632 options to buy
@ $3.19, valued at
$158.3k
|
|
12/20/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/14/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/13/2017 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns:
| Disposed/sold 988,285 shares
@ $0 |
|
04/20/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
04/12/2017 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc
Txns:
| Bought 49,632 options to buy
@ $3.19, valued at
$158.3k
|
|
01/09/2017 |
SC 13G
| Domain Partners VIII, L.P. reports a 9.6% stake in Syndax Pharmaceuticals, Inc. |
03/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/02/2016 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on Syndax Pharmaceuticals Inc |
11/04/2013 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on VERACYTE, INC.
Txns:
| Converted 3,063,294 shares
@ $0 Converted 2,382,322 preferred shares
@ $0 Converted 680,972 preferred shares
@ $0 |
|
10/29/2013 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on VERACYTE, INC. |
07/25/2013 |
SC 13D
| Domain Partners VIII, L.P. reports a 16.7% stake in Ocera Therapeutics, Inc. |
07/16/2013 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on Ocera Therapeutics, Inc. |
08/02/2012 |
SC 13D
| Durata Therapeutics, Inc. reports a 17.4% stake in Durata Therapeutics, Inc. |
07/24/2012 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on Durata Therapeutics, Inc. |
06/15/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
06/04/2012 |
4
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC
Txns:
| Disposed of 1,200,000 shares
@ $0 |
|
08/30/2010 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
08/23/2010 |
3
| Domain Partners VIII, L.P. (10% Owner) has filed a Form 3 on ACHILLION PHARMACEUTICALS INC |